created by various pharmaceutical companies working in concert.
These companies recommended and helped implement a scam where Texas was
to pay for the most expensive new antipsychotics, Abilify, Geodon,
Risperdal, Seroqul and Zyprexa over the older cheaper
antipsychotics. The TMAP scam was exported to many other states.
A 2005 study by the federal government's National Institute of Mental
Health showed that these new antipsychotic drugs, which cost roughly 10
times more than the older drugs, performed no better and had just as
many side effects.
The below Texas article describes how CMAP - The Child version of TMAP
has been suspended over fears that government Medicaid programs have
been influenced by pharmaceutical companies.
Letters to the editor here:
The Dallas Morning News
August 18, 2008
By EMILY RAMSHAW
AUSTIN - A state mental health plan naming the preferred psychiatric
drugs for children has been quietly put on hold over fears drug
companies may have given researchers consulting contracts, speakers fees
or other perks to help get their products on the list.
The Children's Medication Algorithm Project, or CMAP, was supposed to
determine which psychiatric drugs
were most effective for children and in what order they should be tried
at state-funded mental health centers. In April, high-ranking state
health officials gave researchers the go-ahead to roll out the
A month later, the officials delayed the protocol, after Texas Attorney
General Greg Abbott's office objected to it.